Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Swollen joint count increased? 1,933 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,933 reports of Swollen joint count increased have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.4% of all adverse event reports for ADALIMUMAB.

1,933
Reports of Swollen joint count increased with ADALIMUMAB
0.4%
of all ADALIMUMAB reports
1,036
Deaths
1,102
Hospitalizations

How Dangerous Is Swollen joint count increased From ADALIMUMAB?

Of the 1,933 reports, 1,036 (53.6%) resulted in death, 1,102 (57.0%) required hospitalization, and 1,186 (61.4%) were considered life-threatening.

Is Swollen joint count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 1,933 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Swollen joint count increased?

METHOTREXATE (2,068) ABATACEPT (2,032) TOCILIZUMAB (1,987) RITUXIMAB (1,973) DICLOFENAC (1,916) LEFLUNOMIDE (1,907) FOLIC ACID (1,898) PREDNISONE (1,882) ALENDRONATE (1,880) CETIRIZINE (1,880)

Which ADALIMUMAB Alternatives Have Lower Swollen joint count increased Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Swollen joint count increased Reports All Drugs Causing Swollen joint count increased ADALIMUMAB Demographics